{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.580","meta":{"versionId":"5","lastUpdated":"2023-04-03T16:12:03.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CancerLinQ Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-04-03"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.580","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.580"}],"version":"20190319","name":"TrastuzumabAdministeredWithin12MonthsOfDiagnosis","title":"Trastuzumab administered within 12 months of diagnosis","status":"active","experimental":false,"date":"2019-03-19T01:00:22-04:00","publisher":"CancerLinQ Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","concept":[{"code":"G9835","display":"Trastuzumab administered within 12 months of diagnosis"}]}]},"expansion":{"identifier":"urn:uuid:87b5ee73-089b-4482-8846-1eba77f7611c","timestamp":"2023-12-10T21:42:59-05:00","total":0}}